Natco Pharma Ltd News
Patent expiry: A $5 bn opportunity for Indian pharma majors, says report
Lupin, Intas Pharmaceuticals, Sun Pharma, MSN Laboratories, Natco Pharma, Zydus Life Sciences and Dr Reddy's Laboratories are some of the companies, the note said, that could potentially benefit.
 "Patent expiry: A $5 bn opportunity for Indian pharma majors, says report")
Natco Pharma stock price slips 20% in 2 days; should you buy, sell or hold?
Natco Pharma's management expects better FY28 with traction coming from Canada, Brazil and India besides some niche launches in the US which can translate into 15- 25 per cent PAT growth.
 "Natco Pharma stock price slips 20% in 2 days; should you buy, sell or hold?")
10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt
Companies including Dr. Reddy's Laboratories, Sun Pharma, Zydus Lifesciences, Natco Pharma, Alkem Laboratories, and Torrent Pharmaceuticals have developed their own formulations
 "10 pharma firms launch semaglutide in India; Nomura sees ₹12k-cr mkt")
Demerger buzz, semaglutide injection plans sees Natco Pharma shares jump 4%
Demerger: Natco Pharma shares gained nearly 4 per cent in trade on Friday ahead of next week's board meeting to consider a demerger proposal
Natco rallies 5%, nears 52-week high; what's driving pharma stock?
In the past four trading days, the stock price of Natco Pharma has surged 10 per cent after the company announced the launch of Pomalidomide Capsules (generic of Pomalyst) in the US market.
Natco Pharma shares rise 3% in weak mkt on launching generic Pomalyst in US
The buying on the counter came after Natco Pharma, along with Breckenridge Pharmaceutical, launched Pomalidomide Capsules, a generic version of Pomalyst by Celgene, in the US market.
Pharma stocks in demand; Torrent hits new high; Natco up 6% on huge volumes
At 01:13 PM on Tuesday; Nifty Pharma index, the top gainer among sectoral indices, was up 0.2 per cent, as compared to 1.1 per cent decline in the Nifty 50.
 "Pharma stocks in demand; Torrent hits new high; Natco up 6% on huge volumes")
Natco Pharma zooms 11% on getting CDSCO approval for Semaglutide injections
The buying on the counter came after Natco Pharma received approval from the Central Drugs Standard Control Organisation (CDSCO) for Semaglutide in India
Stocks to Watch today: Coal India, SpiceJet, HUL, Biocon, Infosys, IRCTC
Stocks to watch today, Friday, February 13, 2026: Market participants will keep an eye on SpiceJet, Coal India, Biocon, Infosys, Mishra Dhatu Nigam, Indraprastha Gas share prices today
 "Stocks to Watch today: Coal India, SpiceJet, HUL, Biocon, Infosys, IRCTC")